These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9723428)
1. Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections. Casadei D; Rial M; Argento J; Goldberg J; Raimondi E Transplant Proc; 1998 Aug; 30(5):2164. PubMed ID: 9723428 [No Abstract] [Full Text] [Related]
2. Treatment of acute kidney allograft rejection with the nonmitogenic CD3 mAb CLB T3/4.A (IgA-CD3): absence of a correlation of clinical responsiveness with inhibition of lymphocyte reactivity in vitro. Meijer RT; Yong SL; Surachno S; ten Berge IJ; Schellekens PT Transplant Proc; 2001; 33(1-2):1229-30. PubMed ID: 11267271 [No Abstract] [Full Text] [Related]
4. Clinical and renal histologic predictors of long-term outcome after OKT3 therapy for steroid-resistant rejection. Wiener Y; Nakhleh RE; Kupin WL; Lee M; Escobar FS; Venkat KK; Mozes MF Transplant Proc; 1995 Feb; 27(1):1014-5. PubMed ID: 7878781 [No Abstract] [Full Text] [Related]
5. Role of cyclosporine rescue therapy in steroid resistant rejections. Sharma RK; Elhence R; Kher V; Gupta A; Kumar A; Bhandari M; Agrawal S Transplant Proc; 1994 Oct; 26(5):2556-7. PubMed ID: 7940789 [No Abstract] [Full Text] [Related]
6. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection. Midtvedt K; Tafjord AB; Hartmann A; Eide TC; Holdaas H; Nordal KP; Draganov B; Sødal G; Leivestad T; Fauchald P Transplantation; 1996 Jul; 62(1):38-42. PubMed ID: 8693541 [TBL] [Abstract][Full Text] [Related]
7. ATG versus OKT3 in the treatment of steroid-resistant rejection following living-related donor renal transplantation. Uslu A; Tokat Y; Ok E; Unsal A; Ilkgul O; Kaplan H Transplant Proc; 1997 Nov; 29(7):2805-6. PubMed ID: 9365571 [No Abstract] [Full Text] [Related]
9. Long-term efficacy of OKT3 for steroid-resistant acute rejection in renal transplant patients. Kumano K; Irie A; Mashimo S; Endo T; Koshiba K Transplant Proc; 1996 Jun; 28(3):1354-5. PubMed ID: 8658691 [No Abstract] [Full Text] [Related]
10. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection. Casadei DH; del C Rial M; Opelz G; Golberg JC; Argento JA; Greco G; Guardia OE; Haas E; Raimondi EH Transplantation; 2001 Jan; 71(1):53-8. PubMed ID: 11211195 [TBL] [Abstract][Full Text] [Related]
11. Histologic findings and kidney graft outcome in patients with steroid-resistant rejections before and after OKT3 therapy. Niebel W; Metz KA; Albrecht KH; Wagner K; Kribben A; Erhard J; Eigler FW Transplant Proc; 1990 Aug; 22(4):1764. PubMed ID: 2117802 [No Abstract] [Full Text] [Related]
14. Prevention of the OKT3 first-dose syndrome by reduced initial dose followed by adjusted doses based on CD3 T-lymphocyte counts in pediatric renal graft recipients. Piatosa B; Grenda R; Prokurat S Transplant Proc; 1996 Dec; 28(6):3466-7. PubMed ID: 8962349 [No Abstract] [Full Text] [Related]
15. Successful treatment of Epstein-Barr virus infection with ganciclovir and cytomegalovirus hyperimmune globulin following kidney transplantation. Delone P; Corkill J; Jordan M; Krapiva P; Ghasemian R; Sasaki T; Light JA Transplant Proc; 1995 Oct; 27(5 Suppl 1):58-9. PubMed ID: 7482823 [No Abstract] [Full Text] [Related]
16. Use of intravenous immunoglobulin in organ transplantation for noninfectious indications. Yussim A; Klein T; Or H; Shaharabani E; Bar-Nathan N; Shmueli D; Lustig S; Sobolev V; Shapira Z Transplant Proc; 1997 Nov; 29(7):3058-9. PubMed ID: 9365666 [No Abstract] [Full Text] [Related]
17. Comparison of T10Bg.1A-31 and OKT3 in treating acute renal allograft rejection. Lucas BA; Waid TH; Thompson JS; Brown SA; Munch LC; McKeown JW; Kryscio RJ; Prebeck RJ Transplant Proc; 1993 Feb; 25(1 Pt 1):543-5. PubMed ID: 8438406 [No Abstract] [Full Text] [Related]
19. Reduction of the initial febrile response to OKT3 with indomethacin. First MR; Schroeder TJ; Hariharan S; Weiskittel P Transplant Proc; 1993 Apr; 25(2 Suppl 1):52-4. PubMed ID: 8465426 [No Abstract] [Full Text] [Related]
20. Preliminary results of a prospectively randomized trial of ALG vs OKT3 for steroid-resistant rejection after renal transplantation in the early postoperative period. Hesse UJ; Wienand P; Baldamus C; Arns W Transplant Proc; 1990 Oct; 22(5):2273-4. PubMed ID: 2120814 [No Abstract] [Full Text] [Related] [Next] [New Search]